← FDA DRUG APPROVALS

FDA ANDA · ANDA201746

LINCOMYCIN

lincomycin hydrochloride

Sponsor: XGEN PHARMS

APPLICATION
ANDA201746
TYPE
ANDA
ORIGINAL APPROVAL
2015-06-04
LATEST ACTION
2015-06-04
ROUTE
INTRAMUSCULAR, INTRAVENOUS, SUBCONJUNCTIVAL, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

LINCOMYCIN HYDROCHLORIDEPrescription
LINCOMYCIN HYDROCHLORIDE EQ 300MG BASE/ML · INJECTABLE · INJECTION

Approval history

2015-06-04Not Applicable · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →